Picture of GSK logo

GSK GSK News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapSuper Stock

REG - GlaxoSmithKline PLC - Block listing Interim Review

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211115:nRSO4366Sa&default-theme=true

RNS Number : 4366S  GlaxoSmithKline PLC  15 November 2021

 

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

 

Date: 15 November 2021

 

 Name of applicant:                                                                GlaxoSmithKline plc
 Name of scheme:                                                                   GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan
 Period of return:                        From:                                    1 May 2021          To:                 31 October 2021
 Balance of unallotted securities under scheme(s) from previous return:            35,519
 Plus:  The amount by which the block scheme(s) has been increased since the       230,000
 date of the last return (if any increase has been applied for):
 Less:  Number of securities issued/allotted under scheme(s) during period         0
 (see LR3.5.7G):
 Equals:  Balance under scheme(s) not yet issued/allotted at end of period:        265,519

 

 

 Name of applicant:                                                                GlaxoSmithKline plc
 Name of scheme:                                                                   GlaxoSmithKline plc Share Save Plan 2012
 Period of return:                        From:                                    1 May 2021      To:             31 October 2021
 Balance of unallotted securities under scheme(s) from previous return:            382,466
 Plus:  The amount by which the block scheme(s) has been increased since the       3,000,000
 date of the last return (if any increase has been applied for):
 Less:  Number of securities issued/allotted under scheme(s) during period         313,319
 (see LR3.5.7G):
 Equals:  Balance under scheme(s) not yet issued/allotted at end of period:        3,069,147

 

 

 Name of contact:              Victoria Whyte
 Telephone number of contact:  020 8047 5000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BLRFZMMMVKKGMZM

Recent news on GSK

See all news